Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M E Davis

Showing results (311-320 of 326) with videos related to

Pageof 33
Sort By:
Malaria Journal|August 16, 2014
Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malariaStephan Karl, Moses Laman, Tamarah Koleala, et al.
Cardiovascular Diabetology|July 28, 2021
CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countriesOfri Mosenzon, Abdullah Alguwaihes, Jose Luis Arenas Leon, et al.
The New England Journal of Medicine|December 10, 2008
A trial of combination antimalarial therapies in children from Papua New GuineaHarin A Karunajeewa, Ivo Mueller, Michele Senn, et al.
The Lancet. Diabetes & Endocrinology|March 3, 2018
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD studyBoris Waldman, Jean-Claude Ansquer, David R Sullivan, et al.
Plos Medicine|December 31, 2014
Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trialMoses Laman, Brioni R Moore, John M Benjamin, et al.
Plos Medicine|September 14, 2012
Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control studyAnna Rosanas-Urgell, Enmoore Lin, Laurens Manning, et al.
BMC Public Health|August 12, 2021
Prevalence and patterns of multimorbidity in Australian baby boomers: the Busselton healthy ageing studyMichael L Hunter, Matthew W Knuiman, Bill A W Musk, et al.
Contemporary Clinical Trials|November 20, 2019
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerationsAnne T Reutens, Karin Jandeleit-Dahm, Merlin Thomas, et al.
Journal of Hypertension|December 3, 2015
Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohortsJessica L Harding, Manoshayini Sooriyakumaran, Kaarin J Anstey, et al.
International Journal of Cancer|March 27, 2015
Comparison of anthropometric measures as predictors of cancer incidence: A pooled collaborative analysis of 11 Australian cohortsJessica L Harding, Jonathan E Shaw, Kaarin J Anstey, et al.
Pageof 33

Showing results (311-320 of 326) with videos related to

Sort By:
Pageof 33
Malaria Journal|August 16, 2014
Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malariaStephan Karl, Moses Laman, Tamarah Koleala, et al.
Cardiovascular Diabetology|July 28, 2021
CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countriesOfri Mosenzon, Abdullah Alguwaihes, Jose Luis Arenas Leon, et al.
The New England Journal of Medicine|December 10, 2008
A trial of combination antimalarial therapies in children from Papua New GuineaHarin A Karunajeewa, Ivo Mueller, Michele Senn, et al.
The Lancet. Diabetes & Endocrinology|March 3, 2018
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD studyBoris Waldman, Jean-Claude Ansquer, David R Sullivan, et al.
Plos Medicine|December 31, 2014
Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trialMoses Laman, Brioni R Moore, John M Benjamin, et al.
Plos Medicine|September 14, 2012
Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control studyAnna Rosanas-Urgell, Enmoore Lin, Laurens Manning, et al.
BMC Public Health|August 12, 2021
Prevalence and patterns of multimorbidity in Australian baby boomers: the Busselton healthy ageing studyMichael L Hunter, Matthew W Knuiman, Bill A W Musk, et al.
Contemporary Clinical Trials|November 20, 2019
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerationsAnne T Reutens, Karin Jandeleit-Dahm, Merlin Thomas, et al.
Journal of Hypertension|December 3, 2015
Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohortsJessica L Harding, Manoshayini Sooriyakumaran, Kaarin J Anstey, et al.
International Journal of Cancer|March 27, 2015
Comparison of anthropometric measures as predictors of cancer incidence: A pooled collaborative analysis of 11 Australian cohortsJessica L Harding, Jonathan E Shaw, Kaarin J Anstey, et al.
Pageof 33